“Uncovering Aristolochic Acid–Driven Mutational Signatures and Novel Biomarkers inPrimary Hepatic Angiosarcoma for Targeted Therapeutic Development”, PAJHPS, vol. 2, no. 1, Jan. 2026, doi: 10.64261/55166d57.